SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-18-000008
Filing Date
2018-02-20
Accepted
2018-02-16 20:00:41
Documents
5
Period of Report
2018-02-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm 8-K 24644
2 EXHIBIT 99.1 a180216finalfinancingclo.htm EX-99.1 8370
3 a180216finalfinancingclo001.jpg GRAPHIC 222189
4 a180216finalfinancingclo002.jpg GRAPHIC 234968
5 a180216finalfinancingclo003.jpg GRAPHIC 43851
  Complete submission text file 0001583648-18-000008.txt   711971
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 18622776
SIC: 8731 Services-Commercial Physical & Biological Research